Home  >  News
eppen_NEW-Himac_Jan_2026
you can get e-magazine links on WhatsApp. Click here
News
  IntraBio’s Aqneursa receives European Commission’s marketing approval for treatment of Niemann-Pick Type C disease,   January 24, 2026
  AGC Biologics receives US and EU marketing approvals for Waskyra to treat Wiskott-Aldrich syndrome,   January 22, 2026
  EMA validates Enhertu plus pertuzumab type II variation application in EU as first-line treatment of patients with HER2 positive metastatic breast cancer,   January 20, 2026
  European Commission grants marketing approval for Eylea 8 mg to treat macular edema following RVO, including branch, central and hemiretinal vein occlusion,   January 19, 2026
  In 2025 EMA recommends 104 new medicines for marketing approval; 38 had a new active substance,   January 19, 2026
  Venus Remedies receives Indonesian marketing approval for combination antibiotic, ceftazidime+avibactam,   January 15, 2026
  Alphatec Holdings, Theradaptive ink marketing partnership for breakthrough regenerative technology in spinal fusion,   January 14, 2026
  Organon partners with Daiichi Sankyo for commercialization of Nilemdo in France, Denmark, Iceland, Sweden, Finland & Norway,   January 10, 2026
  China NMPA grants marketing approval for ArkBio’s Azstarys for the treatment of ADHD,   January 07, 2026
  CivicaScript announces availability of low-cost insulin and biosimilar for chronic inflammatory conditions in US,   January 06, 2026
  TempraMed deepens Asian market penetration with expanded distribution partnership with Mavericks in South Korea,   January 05, 2026
  Mabwell's adalimumab biosimilar receives Indonesian FDA marketing approval,   January 02, 2026
  Italfarmaco & JCR Pharma enter commercialisation agreement for givinostat to treat Duchenne muscular dystrophy in Japan,   December 29, 2025
  China NMPA grants marketing approval for Innovent Biologics' Tyvyt, a CTLA-4 monoclonal antibody,   December 27, 2025
  Samsung Bioepis’ ustekinumab biosimilar receives Japanese marketing approval,   December 24, 2025
  Sanofi and Regeneron receives Japanese marketing approval for Dupixent to treat bronchial asthma in children aged 6 to 11 years,   December 24, 2025
  Ajanta signs in-licensing agreement with Biocon for marketing semaglutide in 26 countries,   December 23, 2025
  Glenmark Pharma launches epinephrine injection USP in US market,   December 23, 2025
  Emcure expands weight management therapy access with launch of Poviztra,   December 22, 2025
  Fresenius Kabi launches rocuronium bromide injection stable at room temperature,   December 22, 2025

  • Results Found: 7154
  • 1
    •  
  • 2
    •  
  • 3
    •  
  • 4
    •  
  • 5
    •  
  • Go to
  • Total Number of Pages: 358
 Back
 
ASIA_PHARMA_EXPO_2026
Ana_Lab_India_2026
PharmaCore_India_2026
Copyright © 2024 Saffron Media Pvt. Ltd | twitter
 
linkedin
 
 
linkedin
 
instagram